HighVista Strategies’s AbbVie ABBV Stock Holding History

HighVista Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,000	Closed	-$277K	–	113
2018 Q4	$277K	Buy	+3,000	New	+$264K	0.24%	76
2018 Q3	–	Sell	-3,500	Closed	-$324K	–	134
2018 Q2	$324K	Hold	3,500	–	–	0.15%	110
2018 Q1	$331K	Sell	3,500 -400	-10%	-$43.9K	0.14%	117
2017 Q4	$377K	Sell	3,900 -1,800	-32%	-$170K	0.11%	143
2017 Q3	$507K	Sell	5,700 -2,100	-27%	-$160K	0.12%	126
2017 Q2	$566K	Sell	7,800 -3,200	-29%	-$215K	0.13%	115
2017 Q1	$717K	Sell	11,000 -2,500	-19%	-$157K	0.16%	130
2016 Q4	$845K	Sell	13,500 -6,500	-33%	-$397K	0.17%	142
2016 Q3	$1.26M	Sell	20,000 -99,700	-83%	-$6.45M	0.23%	117
2016 Q2	$7.41M	Buy	+119,700	New	+$7.29M	1.42%	14
2015 Q3	–	Sell	-72,442	Closed	-$4.87M	–	181
2015 Q2	$4.87M	Buy	72,442 +68,884	+1,936%	+$4.5M	0.83%	45
2015 Q1	$208K	Sell	3,558 -12,615	-78%	-$762K	0.03%	174
2014 Q4	$1.06M	Sell	16,173 -4,043	-20%	-$255K	0.14%	95
2014 Q3	$1.17M	Buy	+20,216	New	+$1.12M	0.16%	93

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HighVista Strategies's ABBV Position: Q1 2019 in Review

HighVista Strategies sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 3,000 shares — an estimated $277K sold.

HighVista Strategies first reported a position in ABBV in Q3 2014 and held it in 14 quarters. The position peaked at $7.41M in Q2 2016. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

HighVista Strategies reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
HighVista Strategies sold 3,000 AbbVie shares in Q1 2019, an estimated $277K.
HighVista Strategies first reported a position in AbbVie in Q3 2014 and held it in 14 quarters.
HighVista Strategies's AbbVie position peaked at $7.41M in Q2 2016.
2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on HighVista Strategies's 13F filing for Q1 2019, filed 15 May 2019.